The largest database of trusted experimental protocols

4 protocols using su4312

1

Screening of Tyrosine Kinase Inhibitors

Check if the same lab product or an alternative is used in the 5 most similar protocols
SU4312, SU5416, Sorafenib, PTK787 and valproic acid (VPA) were purchased from Sigma-Aldrich with a purity range of > 98% (Table 1).

Chemical properties of tyrosine kinase inhibitors

Inhibitor nameTargetsCAS RNPurity (%)Log KowLog Dlipw at pH 7.4Molecular weight [Da]
SU4312VEGFR2, PDGFR, EGFR, HER-2, IGF (Sun et al. 1998 (link))5812-07-7983.263.73264.32
SU5416

VEGFR2, PDGFR, FIt-1, FIt-4, c-kit

(Haddad 2012 (link))

204005-46-9983.062.09238.28
PTK787

VEGFR2, VEGFR-1, PDGF, FIt-4, and c-Kit

(Gotink and Verheul 2010)

212141-51-0984.980.78419.73
Sorafenib

VEGFR, PDGFR, FGFR1, KIT, RAF

(Gotink and Verheul 2010)

284461-73-0985.305.53464.82
Valproic acid

HDAC1

(Phiel et al. 2001 (link))

99-66-1982.751.9144.21

References for the observation of inhibition and mechanism of action are provided within the “Target” column. Dlipw values were obtained as described in Klüver et al. (2019 (link))

Stock solutions were prepared in 100% dimethyl-sulfoxide (DMSO) and diluted in exposure medium as specified in ISO 7346-3 (1996) [80 mM CaCl2·2H2O, 20 mM MgSO4·7H2O, 31 mM NaHCO3, 3.1 mM KCl]. The final concentration of DMSO was 0.01% (v/v). The pH of the highest test concentration was adjusted to pH 7.4 and all other test concentrations were established by dilution of the highest concentration.
+ Open protocol
+ Expand
2

Diverse Chemical Reagents for Cellular Assays

Check if the same lab product or an alternative is used in the 5 most similar protocols
Chemicals purchased from Cayman Chemical (Ann Arbor, MI) include 5-azacytidine, Bay 11-7085, camptothecin, D-ribofuranosylbenzimidazole, H-8 HCl, kenpaullone, 3,4-Methylenedioxy-β-nitrostyrene (MNS), niclosamide, PD 98059, and topotecan hydrochloride. Citral, DMSO, LY-294002, retinol, and SU 4312 were purchased from Sigma-Aldrich (St. Louis, MO). CD437, ER50891, HX531, and SR11237 were purchased from Torcris (Minneapolis, MN). AM580 was purchased from Enzo Life Sciences (Farmingdale, NY). Chemicals were prepared as stock solution aliquots in DMSO and stored in the vapor phase of liquid nitrogen. Chemicals were protected from extended exposure to light when being prepared and used in assays. The LOPAC was purchased from Sigma-Aldrich and stored following the protocols at the National Center for Advancing Translational Sciences (NCATS) 22 (link). The Cignal lentiviral reagent, which had a lentivirus concentration of 1.7 × 107 transducing units (TU)/ml, was obtained from SABiosciences (Qiagen, Frederick, MD). The MTT cell viability assay kit was obtained from ATCC (Manassas, VA) and used following the manufacturer's instructions.
+ Open protocol
+ Expand
3

Vascular Permeability Signaling Pathways

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were starved in serum-free medium overnight. Cells were treated with 200 μM Na3VO4 in MCDB 131 for 5 min at 37°C, then VEGF (100 ng/ml) in MCDB 131 for 5 minutes , or with GO (1 U/ml) or 500 μM H2O2 in MCDB 131 for 5 to 90 min at 37°C. In experiments using inhibitors, cells were pretreated with the indicated inhibitor for 2 hours at 37°C. Cells were lysed in modified radioimmunoprecipitation (mRIPA) buffer as described previously (47 (link)). For in vivo assays, mice were perfused with 10 ml of 200 μM Na3VO4 in serum free DMEM, then either 10 ml of VEGF (200ng/ml), 1 mM H2O2 or vehicle in serum-free DMEM. Total lungs were lysed in mRIPA (100 μl mRIPA/10mg lung), homogenized, and centrifuged to clear debris. The following inhibitors were used at the indicated concentrations: anti-VEGF antibody, 10 μg/ml (Genentech), SU4312, 20 μM (Sigma), PP2, 10 μM (Millipore), NAC, 0.2 to 4 mM for in vitro experiments, 5mg/ml for mouse experiments (Sigma).
+ Open protocol
+ Expand
4

Cell Synchronization and Arrest Protocols

Check if the same lab product or an alternative is used in the 5 most similar protocols
The VEGFR inhibitors SU4312 (Sigma-Aldrich, St. Louis, MO, USA), A83-01 (StressMarq Bioscience Inc., Victoria, BC, Canada), and Ki8751 (Selleck Chemicals, Houston, TX, USA) were used in the present study. To synchronize cells in M phase, the reversible Cdk1 inhibitor RO-3306 (Selleck Chemicals; Tokyo Chemical Industry, Tokyo, Japan) was used. To arrest cells at metaphase, 10 µM MG-132 (Cayman Chemical, Ann Arbor, MI, USA) was used. These inhibitors were dissolved in dimethyl sulfoxide (DMSO).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!